No black box warning on record for Camrese

As of the latest FDA labeling reviewed, Camrese (LEVONORGESTREL / ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Camrese medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Vascular risks: Stop if a thrombotic or thromboembolic event occurs. Stop at least 4 weeks before and through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding. Consider cardiovascular risk factors before initiating in all females, particularly those over 35 years. ( 5.1 , 5.5 ) Liver disease: Discontinue if jau

No black box warning on record for Camrese

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Vascular risks: Stop if a thrombotic or thromboembolic event occurs. Stop at least 4 weeks before and through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding. Consider cardiovascular risk factors before initiating in all females, particularly those over 35 years. ( 5.1 , 5.5 ) Liver disease: Discontinue if jau

Camrese Black Box Warning

No black box warning on record for Camrese

Other warnings & precautions

Camrese Black Box Warning

No black box warning on record for Camrese

Other warnings & precautions